CBS News @CBSNews
HRA Pharma's application on Monday sets up a high-stakes decision for health regulators amid legal and political battles over women's reproductive health. The company says the timing was unrelated to the recent overturning of Roe v. Wade. https://t.co/D1fi0WGcB8 — PolitiTweet.org